Next Article in Journal
Iron Regulation: Macrophages in Control
Next Article in Special Issue
Development of [131I]I-EOE-TPZ and [131I]I-EOE-TPZMO: Novel Tirapazamine (TPZ)-Based Radioiodinated Pharmaceuticals for Application in Theranostic Management of Hypoxia
Previous Article in Journal
Established and Emerging Concepts to Treat Imbalances of Iron Homeostasis in Inflammatory Diseases
Previous Article in Special Issue
Evaluation of Radiolabeled Girentuximab In Vitro and In Vivo
Article

Synthesis and Initial In Vivo Evaluation of [11C]AZ683—A Novel PET Radiotracer for Colony Stimulating Factor 1 Receptor (CSF1R)

1
Department of Medicinal Chemistry, University of Michigan, Ann Arbor, MI 48109, USA
2
Department of Radiology, University of Michigan, Ann Arbor, MI 48109, USA
*
Authors to whom correspondence should be addressed.
Pharmaceuticals 2018, 11(4), 136; https://0-doi-org.brum.beds.ac.uk/10.3390/ph11040136
Received: 31 October 2018 / Revised: 6 December 2018 / Accepted: 11 December 2018 / Published: 13 December 2018
Positron emission tomography (PET) imaging of Colony Stimulating Factor 1 Receptor (CSF1R) is a new strategy for quantifying both neuroinflammation and inflammation in the periphery since CSF1R is expressed on microglia and macrophages. AZ683 has high affinity for CSF1R (Ki = 8 nM; IC50 = 6 nM) and >250-fold selectivity over 95 other kinases. In this paper, we report the radiosynthesis of [11C]AZ683 and initial evaluation of its use in CSF1R PET. [11C]AZ683 was synthesized by 11C-methylation of the desmethyl precursor with [11C]MeOTf in 3.0% non-corrected activity yield (based upon [11C]MeOTf), >99% radiochemical purity and high molar activity. Preliminary PET imaging with [11C]AZ683 revealed low brain uptake in rodents and nonhuman primates, suggesting that imaging neuroinflammation could be challenging but that the radiopharmaceutical could still be useful for peripheral imaging of inflammation. View Full-Text
Keywords: neuroinflammation; microglia; carbon-11; radiochemistry; positron emission tomography neuroinflammation; microglia; carbon-11; radiochemistry; positron emission tomography
Show Figures

Graphical abstract

MDPI and ACS Style

Tanzey, S.S.; Shao, X.; Stauff, J.; Arteaga, J.; Sherman, P.; Scott, P.J.H.; Mossine, A.V. Synthesis and Initial In Vivo Evaluation of [11C]AZ683—A Novel PET Radiotracer for Colony Stimulating Factor 1 Receptor (CSF1R). Pharmaceuticals 2018, 11, 136. https://0-doi-org.brum.beds.ac.uk/10.3390/ph11040136

AMA Style

Tanzey SS, Shao X, Stauff J, Arteaga J, Sherman P, Scott PJH, Mossine AV. Synthesis and Initial In Vivo Evaluation of [11C]AZ683—A Novel PET Radiotracer for Colony Stimulating Factor 1 Receptor (CSF1R). Pharmaceuticals. 2018; 11(4):136. https://0-doi-org.brum.beds.ac.uk/10.3390/ph11040136

Chicago/Turabian Style

Tanzey, Sean S., Xia Shao, Jenelle Stauff, Janna Arteaga, Phillip Sherman, Peter J.H. Scott, and Andrew V. Mossine 2018. "Synthesis and Initial In Vivo Evaluation of [11C]AZ683—A Novel PET Radiotracer for Colony Stimulating Factor 1 Receptor (CSF1R)" Pharmaceuticals 11, no. 4: 136. https://0-doi-org.brum.beds.ac.uk/10.3390/ph11040136

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop